A phase II study of doxifluridine in patients with advanced breast cancer. 1988

P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
Division d'Onco-Hématologie, Hôpital Cantonal Universitaire, Geneva, Switzerland.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005467 Floxuridine An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. FUdR,Fluorodeoxyuridine,5-FUdR,5-Fluorodeoxyuridine,5 Fluorodeoxyuridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
January 1991, European journal of cancer (Oxford, England : 1990),
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
January 1985, Cancer chemotherapy and pharmacology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
December 1996, American journal of clinical oncology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
December 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
January 2004, Anticancer research,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
September 2000, Oncology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
September 1982, Cancer treatment reports,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
October 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
March 2002, Japanese journal of clinical oncology,
P Alberto, and W F Jungi, and P Siegenthaler, and B Mermillod, and J P Obrecht, and G Decoster, and F Cavalli
September 1998, Cancer,
Copied contents to your clipboard!